Individual Variation of Human Cortical Structure Is Established in the First Year of Life.


Journal

Biological psychiatry. Cognitive neuroscience and neuroimaging
ISSN: 2451-9030
Titre abrégé: Biol Psychiatry Cogn Neurosci Neuroimaging
Pays: United States
ID NLM: 101671285

Informations de publication

Date de publication:
10 2020
Historique:
received: 13 01 2020
revised: 28 04 2020
accepted: 21 05 2020
pubmed: 4 8 2020
medline: 11 3 2021
entrez: 4 8 2020
Statut: ppublish

Résumé

Individual differences in cortical gray matter (GM) structure are associated with cognitive function and psychiatric disorders with developmental origins. Identifying when individual differences in cortical structure are established in childhood is critical for understanding the timing of abnormal cortical development associated with neuropsychiatric disorders. We studied the development of cortical GM and white matter volume, cortical thickness, and surface area using structural magnetic resonance imaging in two unique cohorts of singleton (121 male and 131 female) and twin (99 male and 83 female) children imaged longitudinally from birth to 6 years. Cortical GM volume increases rapidly in the first year of life, with more gradual growth thereafter. Between ages 1 and 6 years, total surface area expands 29%, while average cortical thickness decreases about 3.5%. In both cohorts, a large portion of individual variation in cortical GM volume (81%-87%) and total surface area (73%-83%) at age 6 years is present by age 1 year. Regional heterogeneity of cortical thickness observed at age 6 is largely in place at age 1. These findings indicate that individual differences in cortical GM structure are largely established by the end of the first year of life, following a period of rapid postnatal GM growth. This suggests that alterations in GM structure associated with psychiatric disorders with developmental origins may largely arise in the first year of life and that interventions to normalize or mitigate abnormal GM development may need to be targeted to very early childhood.

Sections du résumé

BACKGROUND
Individual differences in cortical gray matter (GM) structure are associated with cognitive function and psychiatric disorders with developmental origins. Identifying when individual differences in cortical structure are established in childhood is critical for understanding the timing of abnormal cortical development associated with neuropsychiatric disorders.
METHODS
We studied the development of cortical GM and white matter volume, cortical thickness, and surface area using structural magnetic resonance imaging in two unique cohorts of singleton (121 male and 131 female) and twin (99 male and 83 female) children imaged longitudinally from birth to 6 years.
RESULTS
Cortical GM volume increases rapidly in the first year of life, with more gradual growth thereafter. Between ages 1 and 6 years, total surface area expands 29%, while average cortical thickness decreases about 3.5%. In both cohorts, a large portion of individual variation in cortical GM volume (81%-87%) and total surface area (73%-83%) at age 6 years is present by age 1 year. Regional heterogeneity of cortical thickness observed at age 6 is largely in place at age 1.
CONCLUSIONS
These findings indicate that individual differences in cortical GM structure are largely established by the end of the first year of life, following a period of rapid postnatal GM growth. This suggests that alterations in GM structure associated with psychiatric disorders with developmental origins may largely arise in the first year of life and that interventions to normalize or mitigate abnormal GM development may need to be targeted to very early childhood.

Identifiants

pubmed: 32741702
pii: S2451-9022(20)30137-3
doi: 10.1016/j.bpsc.2020.05.012
pmc: PMC7860052
mid: NIHMS1618280
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

971-980

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH111944
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH122779
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103573
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH064065
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD079124
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD040127
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070890
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD053000
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH070890
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH091645
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

Intelligence. 2009 Mar;37(2):145-155
pubmed: 20161325
J Neurosci Methods. 2013 Jan 15;212(1):43-55
pubmed: 23032117
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):12927-32
pubmed: 22826224
JAMA Psychiatry. 2016 Jan;73(1):64-72
pubmed: 26650724
Neuroimage Clin. 2014 Aug 13;6:180-91
pubmed: 25379430
Neuropsychopharmacology. 2020 Mar;45(4):703-712
pubmed: 31694045
Nat Neurosci. 2015 May;18(5):773-8
pubmed: 25821911
Biol Psychiatry. 2012 Aug 1;72(3):191-7
pubmed: 22418014
Cereb Cortex. 2017 Dec 1;27(12):5616-5625
pubmed: 27797836
Dev Med Child Neurol. 2012 Apr;54(4):313-23
pubmed: 22283622
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11366-71
pubmed: 22689983
Neuroimage. 2011 Jan 1;54(1):313-27
pubmed: 20656036
Cereb Cortex. 2015 Aug;25(8):2204-12
pubmed: 24591525
Neuroimage. 2010 Oct 15;53(1):1-15
pubmed: 20547229
Front Neuroinform. 2014 Feb 06;8:7
pubmed: 24567717
Nature. 2011 Oct 26;478(7370):483-9
pubmed: 22031440
Science. 2020 Mar 20;367(6484):
pubmed: 32193296
Cereb Cortex. 2019 Mar 1;29(3):1139-1149
pubmed: 29420697
Cereb Cortex. 2017 Mar 1;27(3):1721-1731
pubmed: 28334080
Cereb Cortex. 2017 Nov 1;27(11):5274-5283
pubmed: 27799276
Nat Rev Neurosci. 2018 Feb 16;19(3):123-137
pubmed: 29449712
Neuron. 2016 Jan 20;89(2):248-68
pubmed: 26796689
Nat Rev Neurosci. 2015 Dec;16(12):756-67
pubmed: 26585800
Cereb Cortex. 2020 Mar 21;30(2):786-800
pubmed: 31365070
BMC Pediatr. 2017 Feb 1;17(1):45
pubmed: 28143492
J Neurosci. 2017 Mar 22;37(12):3402-3412
pubmed: 28242797
Neurobiol Aging. 2016 May;41:86-92
pubmed: 27103521
Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):604-35
pubmed: 24132894
Neuroimage. 2016 Nov 1;141:273-281
pubmed: 27453157
Dev Med Child Neurol. 2019 Apr;61(4):399-405
pubmed: 30276811
Schizophr Bull. 2013 Sep;39(5):1129-38
pubmed: 23042112
Nature. 2017 Feb 15;542(7641):348-351
pubmed: 28202961
Magn Reson Imaging. 2015 Feb;33(2):213-21
pubmed: 25179140
Nature. 2006 Mar 30;440(7084):676-9
pubmed: 16572172
Radiology. 2007 Feb;242(2):535-41
pubmed: 17179400
Cereb Cortex. 2018 Sep 1;28(9):3267-3277
pubmed: 28968835
J Neurosci. 2007 Feb 7;27(6):1255-60
pubmed: 17287499
Neuroimage. 2017 Jun;153:246-261
pubmed: 28392489
Twin Res Hum Genet. 2011 Jun;14(3):268-76
pubmed: 21623657
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
PLoS One. 2013 Dec 11;8(12):e80954
pubmed: 24349025
Med Image Anal. 2005 Oct;9(5):457-66
pubmed: 16019252
Cereb Cortex. 2017 Feb 1;27(2):1125-1136
pubmed: 26656727
Int J Dev Neurosci. 2018 Dec;71:68-82
pubmed: 30172895
Bipolar Disord. 2016 Feb;18(1):4-18
pubmed: 26851067
JAMA Pediatr. 2013 Dec;167(12):1135-42
pubmed: 24165922
Child Neuropsychol. 2020 Feb;26(2):170-188
pubmed: 31385559
Neuron. 2014 Jan 22;81(2):321-32
pubmed: 24373884
Science. 2007 Dec 21;318(5858):1937-40
pubmed: 18096809
Cereb Cortex. 2007 Sep;17(9):2163-71
pubmed: 17118969
Cereb Cortex. 2015 Jul;25(7):1897-905
pubmed: 24488941
Neuron. 2018 Jan 3;97(1):231-247.e7
pubmed: 29276055
Am J Psychiatry. 2018 Apr 1;175(4):359-369
pubmed: 29145754
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9357-62
pubmed: 27432992
J Neurosci. 2008 Apr 2;28(14):3586-94
pubmed: 18385317
Genes Brain Behav. 2010 Apr;9(3):288-95
pubmed: 20100212
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15855-15860
pubmed: 31332010
Am J Psychiatry. 2010 Sep;167(9):1083-91
pubmed: 20516153
Am J Psychiatry. 2016 Mar 1;173(3):232-43
pubmed: 26621570
J Neuropathol Exp Neurol. 1987 May;46(3):283-301
pubmed: 3559630
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671

Auteurs

John H Gilmore (JH)

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: jgilmore@med.unc.edu.

Benjamin Langworthy (B)

Department of Biostatistics, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina.

Jessica B Girault (JB)

Carolina Institute for Developmental Disabilities, Chapel Hill, North Carolina.

Jason Fine (J)

Department of Biostatistics, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina.

Shaili C Jha (SC)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Sun Hyung Kim (SH)

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Emil Cornea (E)

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Martin Styner (M)

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Department of Computer Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH